NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study

Alon Ben-Noon
CEO & Co-Founder of NeuroSense
MBA and BSc in Industrial Engineering, both from Ben-Gurion University
Prior to the establishment of NeuroSense, Alon founded MediCan Consulting, a successful consultancy firm which worked and collaborated with many leading pharmaceutical R&D companies, including Mediwound, Chiasma, Teva, Sol-Gel, FutuRx, NeuroDerm and others. The firm’s diligent employees were pioneers, who paved the way to more efficient and accurate work in the industry, mainly in small biotech companies, while coordinating innovative drug development programs, managing operational activities and business development. Alon holds a MBA and BSc in Industrial Engineering, both from Ben-Gurion University.